Log in or Sign up for Free to view tailored content for your specialty!
Intervention News
Heart breaks & heart wakes: Effects of stress and mindfulness, with Jonathan Fisher, MD
In this episode, host Hansa Bhargava, MD, discusses physician burnout, mindfulness and the effects of stress on heart health with Jonathan Fisher, MD, FACC.
FDA clears IVL catheter for treatment of below-the-knee PAD
Shockwave Medical announced the FDA clearance and full U.S. launch of its peripheral intravascular lithotripsy catheter designed to treat calcified femoropopliteal and below-the-knee peripheral artery disease.
Log in or Sign up for Free to view tailored content for your specialty!
FDA approves 160 cm endovascular navigation wire with 3D imaging guidance
Philips announced the FDA approved the 160 cm version of its endovascular navigation wire that uses fiber optic technology.
Premarket research not conducted for many CV devices subject to class I recall
Many recently recalled cardiovascular devices did not undergo premarket testing prior to FDA approval, and postmarket studies of the devices were slow and infrequent, researchers reported.
Shared decision-making key for invasive vs. conservative MI strategy in elderly: SENIOR-RITA
For older adults with non-STEMI, routine coronary intervention was safe but did not lower risk for death from CV causes or nonfatal MI compared with medical therapy alone, according to new data from the SENIOR-RITA trial.
Fasting not necessary for cardiac catheterization procedures with conscious sedation
Not fasting before cardiac catheterization procedures with conscious sedation was noninferior and likely superior to fasting for safety, and improved patient satisfaction, researchers reported at the European Society of Cardiology Congress.
TAVR superior to surgery at 1 year for women with severe aortic stenosis: RHEIA
Women with symptomatic severe aortic stenosis had better outcomes at 1 year after transcatheter aortic valve replacement with a balloon-expandable valve compared with women who underwent surgery, according to new data from the RHEIA trial.
Coronary implant noninferior to DES at 1 year, tied to event reduction after 6 months
The bioadaptor implant adaptable to vessel physiology was noninferior to a drug-eluting stent for target lesion failure at 1 year, and reduced event rates vs. the DES after 6 months, researchers reported.
Temporary interruption of anticoagulant use during TAVR appears safe
Halting oral anticoagulation during transcatheter aortic valve replacement was not noninferior to anticoagulant continuation, but conferred lower bleeding risk and had no impact on thromboembolic risk, a speaker reported.
Patients with CAD undergoing TAVR may also benefit from angioplasty
In patients with coronary artery disease and severe aortic stenosis undergoing transcatheter aortic valve replacement, those who also had PCI had better outcomes than those who had their CAD managed conservatively, researchers reported.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read